November 2019

The researcher Purificación Muñoz receives the V Martí Via prize

Ageing and Cancer, Cancer, Head and neck diseases  / By

Dr. Purificación Muñoz, a researcher at the IDIBELL (Oncobell Program), has been awarded with the V Martí Vía Prize for cancer research, an award given annually by the Vallformosa Foundation and GESCO Family. The grant is endowed with 30,000 euros. This amount is assigned, year after year, to professionals and researchers from areas related to pediatric […]

The researcher Purificación Muñoz receives the V Martí Via prize Read More »

ICO and IDIBELL researchers study the risk of false positives in colon screening during the period 2000-2017

Cancer, Colorectal Cancer, Early Detection of Cancer / By

Screening programs allow to detect the disease when it is in its initial stages to treat it in time and increase the chances of cure. Despite its benefits, there may be a small group of patients who may suffer the consequences of a ‘false positive’, this means that the blood found in the stool may be due to benign pathologies and not cancer.

ICO and IDIBELL researchers study the risk of false positives in colon screening during the period 2000-2017 Read More »

Resolution of the Call for Expression of Interest (EoI) for Collaborative Projects on Regenerative Medicine 2019

Leave a Comment / Diabetes, Nutrition and endocrinological diseases , Nephrology and renal transplantation, Neurometabolic diseases , Pluripotent Stemm Cell Therapy , Regenerative Medicine Program, Stem Cell Potency  / By

Once the period for applications submission is finished, all the documentation provided has been reviewed and the list for funded EoI is approved. The Assessment Committee, met on October 8th, in accordance with the criteria described in the call, has evaluated the Collaborative Projects and has raised a list of proposals selected to be funded.

Resolution of the Call for Expression of Interest (EoI) for Collaborative Projects on Regenerative Medicine 2019 Read More »

Dr. Silvia de Sanjosé recognized as one of the most influential researchers of the decade

Leave a Comment / Cancer, Infections and Cancer / By

Dr. Silvia de Sanjosé (IDIBELL-ICO) has been recently recognized as a Highly Cited Researcher. She leads the Infections and Cancer group, whose research focuses on the fight between viruses and hosts from an evolutionary perspective: the antiviral mechanisms which animals have developed and the antiviral strategies which have contributed to virus selection. They explore the

Dr. Silvia de Sanjosé recognized as one of the most influential researchers of the decade Read More »

IDIBELL and Pharmacelera sign a research agreement to find new drugs with anticancer applications

Leave a Comment / Cancer, Cell Cycle / By

Researchers at Bellvitge Biomedical Research Institute will develop a research project with the company Pharmacelera to look for new molecules that block the cohesin complex, with applications in several difficult-to-treat cancers, such as myeloid leukemia, glioblastomas, Ewing sarcomas, colon cancer and bladder cancer

IDIBELL and Pharmacelera sign a research agreement to find new drugs with anticancer applications Read More »

The first Edition of Sinergia opened doors to research and innovation of L’Hospitalet

Cancer, Cardiovascular, Respiratory and Systemic Diseases and cellular aging Program, Neuroscience Program, Outreach and education, Regenerative Medicine Program, Synovial inflammation and bone metabolism , Traslacional Medicine / By

More than 300 people attended the festival of research & innovation on health, held at IDIBELL.

The first Edition of Sinergia opened doors to research and innovation of L’Hospitalet Read More »

Here comes Sinergia, the festival of research and innovation in health of L’Hospitalet

Cancer, Neuroscience Program, Outreach and education, Regenerative Medicine Program, Traslacional Medicine / By

Saturday, November 16, from 10 a.m. to 2 p.m., open day at the facilities of the Duran i Reynals Hospital. This event wants to showcase the responsible and innovative research carried out at the Bellvitge Biomedical Pole

Here comes Sinergia, the festival of research and innovation in health of L’Hospitalet Read More »

Innovation for value analyzes the use of big data and the new power it gives to patients

Innovation / By

The conference on health innovation Innovation for value, held on November 8 in Barcelona, ​​has analyzed the opportunities offered by technological advances in the field of health. The conference, organized by the Bellvitge Biomedical Research Institute (IDIBELL) and the Platform for Innovation in Medical and Health Technologies (ITEMAS), has been attended by some of the

Innovation for value analyzes the use of big data and the new power it gives to patients Read More »

Scroll to Top